The European Medicines Agency (EMA) has recommended the approval of two lymphoma medications:  Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel). The EMA’s decision represents the first two recommendations for chimeric antigen receptors ... Read more